SARS-CoV-2 & Flu A/B by LumiraDx

Manufacturer LumiraDx  |  Available Worldwide
Is it COVID-19? Is it Flu? Lab-comparable results in minutes. Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results in 12 mins for patients suspected of Flu and/or COVID-19, to help decision making and guide treatment.


SARS-CoV-2 & Flu A/B by LumiraDx product image
SARS-CoV-2 & Flu A/B
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Test benefits

  • Microfluidic immunofluorescence assay
  • Optimize patient and clinical flow - 1 sample, 3 results, 12 mins
  • Sample type: nasal swab
  • Easy to implement at point of care
  • Time to result in as quick as 12 minutes
  • No refrigeration storage required: room temperature storage (2°C to 30 °C)
  • Portable Instrument for near-patient testing
  • Minimal handling steps